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Abstract
Cells of the neural stem cell lineage in the adult subventricular zone (SVZ) respond to brain insult by increasing their
numbers and migrating through the rostral migratory stream. However, in most areas of the brain other than the SVZ and
the subgranular zone of the dentate gyrus, such a regenerative response is extremely weak. Even these two neurogenic
regions do not show extensive regenerative responses to repair tissue damage, suggesting the presence of an intrinsic
inhibitory microenvironment (niche) for stem cells. In the present study, we assessed the effects of injection of clustered
ephrin-A1-Fc into the lateral ventricle of rats with unilateral nigrostriatal dopamine depletion. Ephrin-A1-Fc clustered by
anti-IgG(Fc) antibody was injected stereotaxically into the ipsilateral lateral ventricle of rats with unilateral nigrostriatal
lesions induced by 6-hydroxydopamine, and histologic analysis and behavioral tests were performed. Clustered ephrin-A1-
Fc transformed the subventricular niche, increasing bromodeoxyuridine-positive cells in the subventricular area, and the
cells then migrated to the striatum and differentiated to dopaminergic neurons and astrocytes. In addition, clustered
ephrin-A1-Fc enhanced angiogenesis in the striatum on the injected side. Along with histologic improvements, behavioral
derangement improved dramatically. These findings indicate that the subventricular niche possesses a mechanism for
regulating both stem cell and angiogenic responses via an EphA–mediated signal. We conclude that activation of EphA
receptor–mediated signaling by clustered ephrin-A1-Fc from within the lateral ventricle could potentially be utilized in the
treatment of neurodegenerative diseases such as Parkinson’s disease.
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Introduction
Self-renewal and differentiation of somatic stem cells are
regulated by the stem cell environment (niche) via as yet undefined
mechanisms [1]. Glial fibrillary acidic protein (GFAP)–positive
cells give rise to neurons and interact directly with other cells in the
subventricular zone (SVZ) and subgranular zone (SGZ). They are,
therefore, regarded as neural stem cells [2,3]. Ependymal cells
surrounding the lateral ventricle are in close proximity with these
cells in the SVZ and produce stem cell–activating factors [4,5].
Blood vessel endothelial cells are another critical component of the
SVZ [6]; dividing neural stem/progenitor cells (NSPCs) are tightly
apposed to SVZ capillary vessels [7]. These findings suggest that
GFAP–positive cells, ependymal cells, and capillary endothelial
cells may function as niche cells.
Lesions to the brain initiate the proliferation of NSPCs and
neurogenesis in the SVZ [8,9]. A major proportion of proliferating
neuroblasts in the SVZ migrate to the olfactory bulb and become
interneurons [10]. Because the striatum is closely associated with
the SVZ, NSPCs there would be an ideal source of cellular
replacements for the damaged striatum. In rats with lesions of the
nigrostriatal pathway, the natural response of cellular proliferation
in the SVZ is weak and disappears within a few weeks [9]. In this
case, some NSPCs originating in the SVZ can migrate to the
adjacent striatum, but few differentiate to neurons [9,10].
Ephrins signal via EphA and EphB receptor tyrosine kinases
(forward signaling), and Eph receptors also transmit signals via
ephrins (reverse signaling) [11]. EphAs bind to ephrin-As anchored
to the cell membrane via a glycosylphosphatidylinositol linkage.
EphBs bind to ephrin-Bs, which have a transmembrane domain
and a short cytoplasmic domain. Eph/ephrin signals play
important stimulatory and inhibitory roles in boundary formation,
cell migration, repulsive axon guidance [12], and regulation of
neuronal growth cone development [13]. They also regulate cell-
matrix interactions [14,15,16] and cell proliferation [17,18].
Recent reports suggest that Eph receptors regulate angiogenesis
in embryonic and adult tissues [19].
Neurogenesis is regulated by many factors, among which several
ephrins and their Eph receptors play important roles. They are
differentially expressed on distinct cell types of the neurogenic
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survival and differentiation. EphA2, EphA3 and EphA4 receptors
are expressed in the SVZ, and involved in NSPC differentiation
towards neuronal lineage in vitro [20]. EphA4 appears to be
expressed in the adult neurogenic niches exclusively by neural stem
cells, and function to maintain neural stem cell proliferation [21].
Complimentary expression of ephrin-A2 in transit-amplifying cells
and neuroblasts and that of EphA7 on ependymal cells and neural
stem cells (NSCs) inhibits neural progenitor proliferation through
reverse signaling [22]. EphA7 is shown to be involved in the
modulation of apoptosis of neural progenitors during embryonic
development [23]. Infusion of the ectodomain of either EphB2 or
ephrin-B2 into the lateral ventricle disrupts migration of neuroblasts
and increase cell proliferation [24]. Ephrins B2 and B3 and their
receptor EphB1 suppress proliferation and survival of NSPCs and
migration of neuroblasts in the SVZ, rostral migratory stream
(RMS) and SGZ [25,26]. EphB2 induces proliferation of SVZ cells
in vitro [27]. EphB3 signal suppresses NSPC proliferation in a p53-
dependent manner [28]. Ephrin-B1 is shown to be critical for
maintenance of NSPCs [29].
Fibroblast growth factor receptors (FGFRs) are also tyrosine
kinases that attract and phosphorylate a variety of signaling
proteins when activated, forming an assembly of signaling
complexes that activates multiple signaling pathways [30]. FGF
promotes proliferation of neural stem cells [31,32], and FGF
activity has been implicated in the maintenance of stem cell niches
in vivo [33]. We recently reported that interaction of activated
EphA4 with FGFRs augments proliferative signaling via fibroblast
growth factor receptor substrate 2a (FRS2a) [34,35] and that
coactivated FGFRs stimulate migration-related signal through
RhoA by phosphorylating Ephexin1 [36]. These findings suggest-
ed to us that there might be an intrinsic regulatory mechanism of
ephrin-A/EphA–mediated signaling in the neural stem cell niche.
In the present study, we show that ephrin-A/EphA–mediated
signaling plays a role in neuronal regeneration in a rat model of
Parkinson’s disease.
Materials and Methods
Ethics Statement
All animal experiments were performed in compliance with the
guidelines of the Animal Experiment Committee of the
Wakayama Medical University in accordance with the Act on
Welfare and Management of Animals (Law No. 105, Japan), the
Fundamental Guidelines for Proper Conduct of Animal Experi-
ment and Related Activities in Academic Research Institutions
(Japanese Ministry of Education, Culture, Sports, Science and
Technology, Notice No. 71, 2006), and the Standards Relating to
the Care and Management of Laboratory Animals and Relief of
Pain (Japanese Ministry of Environment, Notice No. 88, 2006).
Our proposed studies entitled, ‘‘Studies on the effect of
subventricular stem cell stimulation in situ in a rat model of
Parkinson’s disease’’, have been approved by the committee under
the institutional approval numbers of #141 (from April 1, 2004 to
March 31, 2006) and #258 (from June 1, 2006 to May 31, 2011).
Preparation of Clustered Ephrin-A1-Fc, Clustered IgG(Fc),
and FGF2
Recombinant mouse ephrin-A1 fused by means of a polypeptide
linker to the Fc portion of human IgG1 (ephrin-A1-Fc) was
purchased from Sigma-Aldrich (St. Louis, MO; Cat. #E9902). To
prepare clustered ephrin-A1-Fc, 20 mg ephrin-A1-Fc was incubated
with 48 mg rabbit anti-human IgG(Fc) antibody (Jackson Immu-
noResearch Laboratories, West Grove, PA; Cat. #309-005-008) in
30 ml phosphate-buffered saline (PBS) at 4uC for $1 hour. As a
control, a human IgG(Fc) fragment (Jackson ImmunoResearch
Laboratories; Cat. #009-000-008) was subjected to the same
treatment. Recombinant human FGF2 was from R&D Systems
(Minneapolis, MN) and dissolved in PBS containing 0.1% heat-
inactivated bovine serum albumin (BSA) at 10 mg/ml for storage
and diluted further with PBS for injection or infusion. For injection,
3 mg ephrin-A1-Fc or IgG(Fc) or 100 ng FGF2 was used in a
volume of 3–4 ml. For infusion through a 100 ml microosmotic
pump, 2–3 mg/day ephrin-A1-Fc or IgG(Fc) or 50 ng/day FGF2
was infused into the lateral ventricle. Ephrin-A1-Fc and IgG(Fc)
were used with or without clustering as specified in each study.
Unilateral Lesioning of the Nigrostriatal Dopaminergic
Pathway
Male Sprague Dawley rats (7–9 weeks old) were injected
stereotaxically with 2 ml saline containing 6 mg/ml 6-hydroxydom-
pamine (6OHDA) and 0.2% ascorbic acid into the right medial
forebrain bundle (coordinates: anterior/posterior 22.2 mm,
lateral [right] 1.5 mm relative to bregma, dorsoventral
28.0 mm from the dural surface) under anesthesia. Rats were
examined for typical rotational behavior after intraperitoneal
apomorphine injection (0.5 mg/kg) 6–8 weeks after injection of
6OHDA. Rats that rotated on average more than 100 times in
20 minutes when measured in 3 successive 20-minute periods were
regarded as having severe dopamine deficiency (unilaterally
lesioned rats) [37]. These unilaterally lesioned rats were always
used 6–8 weeks after lesioning with 6OHDA.
Intraventricular Injection
Rats were anesthetized with ketamine (60 mg/kg) and xylazine
(10 mg/kg), and reagents were injected or were infused with a
microosmotic pump (Alzet 1007D; Durect Corp, Cupertino, CA)
into the lesioned side (usually right side) of the lateral ventricle
(coordinates: anterior/posterior 20.9 mm, lateral [right] 1.5 mm
relative to bregma, dorsoventral 25.0 mm from the dural surface).
Reagents included clustered IgG(Fc) (3 mg/injection or 3 mg
infusion/day), unclustered ephrin-A1-Fc (3 mg/injection or 3 mg
infusion/day), clustered ephrin-A1-Fc (3 mg/injection or 3 mg
infusion/day), or FGF2 (100 ng/injection or 50 ng infusion/day).
In some experiments, rats were infused with these reagents for 1
week after injection of 1 mg Chloromethylbenzamido-DiI (CM-
DiI, C-7001, Molecular Probes) dissolved in 2 ml of solution
containing 5% DMSO in 300 mM sucrose. Rats were examined
for rotational behavior periodically after intraperitoneal injection
of apomorphine (0.5 mg/kg).
RNA Extraction and RT-PCR
Tissue facing the ventricle (,100 mm in depth) was microdis-
sected under a stereomicroscope. RNA extraction was performed
with TRI reagent (Sigma-Aldrich). Reverse transcription (RT) was
performed with MuLV reverse transcriptase and an oligo d(T)16
reverse transcription primer in 20 ml (Gene Amp RNA PCR kit;
Roche, Indianapolis, IN). Polymerase chain reaction (PCR) was
performed with 35 2-step cycles of 30 seconds at 94uC and
45 seconds at 58uC using 3 ml of the RT product and GoTaq
polymerase (Promega, Madison, WI). The PCR products were
fractionated on 2% agarose gels, and bands were stained with
ethidium bromide and detected under ultraviolet irradiation.
Amplified PCR products were confirmed to have the expected
base sequence by DNA sequencing from both ends. Primers for
reverse transcription polymerase chain reaction (RT-PCR) are
listed in Table S1.
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Rats were anesthetized and perfused with ice-cold PBS followed
by 4% paraformaldehyde, and brains were removed and fixed in
4% paraformaldehyde overnight at 4uC. Brains were cryopro-
tected in a PBS series containing increasing concentrations (10%,
20%, 30%) of sucrose. Indirect immunohistochemistry was
performed with 40-mm-thick, free-floating, coronal sections. For
detection of bromodeoxyuridine (BrdU), sections were rinsed in
PBS and incubated in formamide in 26 saline-sodium citrate
(SSC) (50%, v/v) for 2 hours at 65uC followed by a 15-minute
rinse in 26 SSC at 37uC. The DNA was then treated with 2 N
HCl for 30 minutes at 37uC followed by a 10-minute rinse in
0.1 M boric acid buffer, pH 8.5. Then, the following steps were
performed as routine immunohistochemical staining. Tissue
sections were permeabilized with 0.25% Triton X-100 in PBS
mixed with 1% normal rabbit serum and incubated with primary
antibodies at 4uC for 48 hours. After a wash in PBS, they were
incubated with second antibodies (DAKO) conjugated to horse-
radish peroxidase (for 3,39-diaminobenzidine staining) or Alexa
Fluor 488 and Alexa Fluor 568 (Molecular Probes) at 4uC for
2 hours, followed by a wash in PBS. Sections were counterstained
with 49,6-diamino-2-phenylindole (DAPI; Molecular Probes) or
with Wheat Germ Agglutinin-Alexa Fluor 488 Conjugate
(Molecular Probes) as necessary, and mounted with Gel/Mount
(Biomeda Corp, Foster City, CA). Staining with 3,39-diaminoben-
zidine was detected with a Nikon Eclipse E800 microscope or a
Keyence BZ-9000 microscope. Immunofluorescence was detected
with a Keyence BZ-9000 microscope, Nikon Eclipse E800
fluorescence microscope, Nikon Eclipse TE300 inverted micro-
scope, BioRad Radiance 2000 confocal microscope, or a Zeiss
LSM5 Pascal confocal microscope. Antibodies used in this study
were listed in Table S2.
When quantification is needed, we counted the number or
measured the area of the marker-labeled cells in 8 areas
(9610
4 mm
2/area and 10 mm thickness) per animal from 4 equally
spaced coronal sections of striatum or sagittal sections of the
granule cell layer of the olfactory bulb, and the calculated average
value was taken as representing the animal. The selected areas in
the striatum were 500–800 mm lateral from the lateral wall of the
lateral ventricle and around the center between the dorsal and
ventral edge of the striatum in each section.
Immunoprecipitation and immunoblotting
Immunoblotting of Ephs was performed with brain tissue
lysate that was taken from the brain region (100 mm thickness)
surrounding the ventricles, and lysate containing 200–300 mg
total protein was incubated with unclustered ephrin-A1-Fc or
specific EphA antibodies followed by immunoprecipitation with
protein A agarose. Lysis buffer contained 50 mM HEPES, 1%
Triton X-100, 5 mM ethylenediaminetetraacetic acid, 50 mM
NaCl, 10 mM sodium pyrophosphate, 50 mM sodium fluoride,
1 mM sodium orthovanadate, and protease inhibitors (1 mM
phenylmethylsulfonyl fluoride, 1 mMa p r o t i n i n ,1mM leupep-
tin, and 1 mM pepstatin A). Immunoprecipitated proteins were
fractionated by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis, blotted onto polyvinylidene fluoride mem-
branes (Millipore, Billerica, MA), and incubated with EphA-
specific antibodies (Santa Cruz Biotechnology, Santa Cruz, CA)
or mouse monoclonal antiphosphotyrosine antibody (clone
4G10; Millipore, Billerica, MA). Immunodetection was per-
formed with an Immobilon Western Blotting Detection System
( M i l l i p o r e ,B i l l e r i c a ,M A ) .A n t i b o d i e su s e di nt h i ss t u d yw e r e
listed in Table S2.
BrdU Labeling
BrdU (20 mg/ml) dissolved in PBS was injected into the
peritoneal cavity (80 mg/kg) at intervals of several hours, as
indicated.
Stereologic Cell Counting
Stereologic analysis was performed under blinded conditions on
coded slides. For each rat, we analyzed the entire striatum on the
lesioned and reagent (ephrin-A1-Fc or IgG[Fc])-infused side.
Numbers of BrdU(+) cells were determined in every tenth section
in a series of 40 mm coronal sections throughout the rostrocaudal
extent of the striatum with a semiautomatic stereology system
(Stereoinvestigator; MicroBrightField, Williston, VT) and a 56
objective to trace the striatum. Volume was determined by
summing traced areas of each brain and multiplying by
intersection distance (400 mm). Our criterion for selecting
individual BrdU(+) nuclei was the presence within the counting
frame or touching the right or top frame lines but not touching the
left or bottom lines.
Statistical Analysis
All the values were expressed as mean 6 SD. Comparison of 2
values was performed with Student t-test, or with a nonparametric
analysis, Mann Whitney test. Comparison of $3 values was
performed by one-way analysis of variance followed by Tukey
multiple comparison test.
Results
Expression of EphA Receptors, FGFRs and their
downstream molecules in Adult Subventricular Tissue
and Activation of EphA4 by Clustered Ephrin-A1-Fc
To examine expression of the molecules related to the ephrin/
Eph signal transduction pathway, we extracted RNA from the
microdissected subventricular area (100 mm thickness from the
surface of the ventricles), and performed RT-PCR using the
primers shown in Table S1 (Fig. 1A). All Epha mRNAs and those
for ephrin-A2, -A3, and -A5 (Efna2, Efna3, and Efna5) were
expressed in the SVZ, but those for ephrin-A1 and -A4 (Efna1 and
Efna4) were barely detectable or undetectable. mRNAs for Fgfrs,
Frs2a, and Ephexin1 were also expressed.
To investigate which EphA receptors possibly bind to the
recombinant ephrin-A1-Fc, we incubated the tissue lysate from the
subventricular area with unclustered ephrin-A1-Fc, followed by
immunoprecipitation with protein A-agarose. Only EphA4 was
co-immunoprecipitated and detectable (Fig. 1B). These findings
suggest that the clustered ephrin-A1-Fc used in the current study
predominantly binds to EphA4 in the SVZ. We obtained the same
results using the microdissected subventricular tissue from normal
rats and rats with unilaterally lesioned nigrostriatal dopaminergic
pathway described below. Studies were repeated 3 times in both
normal and lesioned rats, and showed the same results.
To examine the effect of ephrin-A1-Fc on the cells of SVZ, we
used rats with a unilaterally lesioned nigrostriatal dopaminergic
pathway because the evaluation of striatal dopamine depletion and
repletion is standardized. The nigrostriatal dopaminergic pathway
of rats was lesioned 6–8 weeks before intraventricular injection of
clustered ephrin-A1-Fc or other reagents. Clustered or unclustered
ephrin-A1-Fc, clustered IgG(Fc), or FGF2 was injected stereotax-
ically into the lateral ventricle on the lesioned side. Immunoblot-
ting with anti-phosphtyrosine antibody 18 hours after injection
showed that clustered ephrin-A1-Fc phosphorylated EphA4,
however, FGF2, unclustered ephrin-A1-Fc or clustered IgG(Fc)
Ephrin-A1-Mediated Dopaminergic Neurogenesis
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clustered ephrin-A1-Fc was injected.
Effect of Clustered Ephrin-A1-Fc in Rats with Unilateral
Nigrostriatal Pathway Lesions
To roughly locate the area of brain that responds to ephrin-A1-
Fc treatment, we injected clustered ephrin-A1-Fc into the striatum
close to the SVZ. Injection of clustered ephrin-A1-Fc (3 mg)
induced the appearance of tyrosine hydroxylase (TH)–positive (+)
neuronal fibers on the side of the ventricle 4–12 weeks after
injection, but not on the striatal side (Fig. 2A). Intraventricular
injection of clustered ephrin-A1-Fc ipsilateral to the lesion
increased the number of TH(+) neurons on the lesioned side of
the striatum. These were clearly localized as multiple islands in the
ephrin-A1-Fc-injected, lesioned side of the striatum 4–12 weeks
after injection, although they were not yet distributed as densely as
on the normal side (Fig. 2B; Fig S1). We confirmed similar
intrastriatal and intraventricular effects of clustered ephrin-A1-Fc
in 2–3 rats at each time point after injection (4, 6, 8, and 12 weeks).
Behavior of Rats with Unilateral Dopamine Depletion
before and after Treatment with Clustered Ephrin-A1-Fc
Rotation frequency after injection of clustered IgG(Fc) or
ephrin-A1-Fc was analyzed before and 6 weeks after treatment in
the rats treated with a single injection, and before and 4–12 weeks
after treatment in the rats treated with a 7-day infusion. A single
intraventricular injection of clustered ephrin-A1-Fc (3 mg) signif-
icantly decreased rotation frequency to about 60% of that of
IgG(Fc) injection at 6 weeks after treatment, (p,0.01, n=7)
(Fig. 3A). A 7-day continuous ventricular infusion of clustered
ephrin-A1-Fc (2 mg/day) also decreased rotation frequency at 8
and 12 week points, to 53% and 40%, respectively, as compared to
the value before infusion (p,0.01, n=5) (Fig. 3B).
Distribution of BrdU(+) Cells from the Ventricular Side to
the Striatum after Intraventricular Injection of Clustered
Ephrin-A1-Fc
To study possible distribution of BrdU(+) cells along the SVZ-
striatum axis, rats were treated with a single intraventricular
injection of clustered ephrin-A1-Fc (3 mg) to the lesioned side of
the lateral ventricle, followed by 3 intraperitoneal injections of
BrdU (80 mg/kg) at 6-hour intervals, and killed 1, 7, or 14 days
after the ephrin injection. Coronal brain sections were stained for
nuclear BrdU incorporation. Cells on both sides of the SVZ
showed extensive BrdU incorporation 1 day after ephrin injection
(6 h after the last BrdU injection). The BrdU(+) cells ipsilateral to
the ephrin injection side, which is also the lesioned side, showed
dense BrdU(+) cell populations moving toward the periphery of
Figure 1. Expression of EphA–related signaling molecules in subventricular zone cells. (A) RT-PCR for Ephas, Efnas, Fgfrs, Ephexin1, and
Frs2a. G: Glyceraldehyde 6-phosphate dehydrogenase. For Efna1 and Efna4, liver RNA was also used as control. (B) Detection of EphA receptors that
binds to ephrin-A1-Fc in rat brain lysate. Rat brain subventricular cell lysate was incubated with ephrin-A1-Fc, precipitated by protein A-agarose, and
immunoblotted with the antibodies for EphAs. (C) EphA4 phosphorylation in tissue surrounding the lateral ventricle. In rats with lesioned unilaterally
in the nigrostriatal dopaminergic pathway, subventricular tissue was collected 18 hours after single injection of clustered IgG(Fc) (3 mg), unclustered
ephrin-A1-Fc (Un-A1) (3 mg), clustered ephrin-A1-Fc (C-A1) (3 mg), or FGF2 (100 ng). The tissue lysate (450 mg protein) was immunoprecipitated with
anti-EphA4 antibody followed by immunoblotting with anti-phosphotyrosine (pY) antibody and anti-EphA4 antibody.
doi:10.1371/journal.pone.0032019.g001
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shown by vertical lines), whereas BrdU(+) cells did not migrate to
the striatum on the nonlesioned and non-ephrin-injected sides
(Fig. 4A, B). Unilaterally lesioned rats injected with clustered
IgG(Fc) followed by intraperitoneal BrdU injection did not show
such effect (Fig. 4C, D). These studies were repeated in 3 rats for
each treatment and each time point, and showed similar results. A
possible diffusion of ephrin-A1-Fc into the striatum was also
examined immunohistochemically in the brain sections using
fluorescence-labeled anti-human IgG(Fc) antibody. The results
showed no detectable staining (data not shown).
Tracking of Migrating BrdU(+) Cells with CM-DiI from the
Subventricular Zone to the Striatum and Olfactory Bulb
To study whether clustered ephrin-A1-Fc increased the number
of the BrdU(+) cells in the striatum, and to compare the effect with
that of unclustered ephrin-A1-Fc or FGF2, the unilaterally
lesioned rats were infused with clustered IgG(Fc) (3 mg/day),
unclustered ephrin-A1-Fc (3 mg/day), clustered ephrin-A1-Fc
(3 mg/day), or FGF2 (50 ng/day) into the lateral ventricle of the
lesioned side continuously for 1 week with simultaneous
intraperitoneal injection of BrdU (80 mg/kg) twice a day (every
12 hours). Brains were removed 6 weeks after the start of infusion,
sliced into 40-mm thick coronal sections, and stained for BrdU. We
counted the number of BrdU(+) cells in 8 areas (9610
4 mm
2) per
animal in the striatum and in the granule cell layer of the olfactory
bulb as described in the Materials and Methods section (Fig S2). In
the striatum, clustered ephrin-A1-Fc, but not unclustered ephrin-
A1-Fc or FGF2, increased the number of BrdU(+) cells by ,4-fold
over clustered IgG(Fc) treatment. In the olfactory bulb, the normal
target of subventricular neuroblasts migration [38], clustered
ephrin-A1-Fc and FGF2, but not unclustered ephrin-A1-Fc,
increased the number of BrdU(+) cells significantly over clustered
IgG(Fc) treatment. To clarify if the increase of BrdU(+) cells was
extended to all over the striatum, we performed stereologic
counting to quantify precisely the number of BrdU(+) cells
throughout the striatum on the treated side after infusion of
clustered ephrin-A1-Fc or IgG(Fc) and found that clustered
ephrin-A1-Fc increased the number significantly (,2.5-fold) over
IgG(Fc) treatment (Fig. 5A).
Then, to study whether the ephrin-A1-Fc-induced distribution
of BrdU(+) cells in the striatum was caused by migration of NSPCs
from the SVZ, we injected CM-DiI into the lesioned side of the
lateral ventricle right before infusion of clustered ephrin-A1-Fc
and covalently labeled the cells exposed to the ventricular surface
with the fluorescent dye. Brains were removed 6 weeks after the
start of ephrin-A1-Fc infusion, sliced into 40-mm thick coronal
sections, and stained for BrdU. Brain slices were stained for BrdU
and with Wheat Germ Agglutinin conjugated with Alexa Fluor
488 (Molecular Probes), and confocal 3D micrographs were taken
at 1-mm intervals. Then, ten serial confocal micrographs were
compiled for one all-in-focus micrograph, and the number of cells
labeled with BrdU or co-labeled with both BrdU and CM-DiI was
counted in selected areas. When cells 500–800 mm lateral from the
ventricular surface were examined 6 weeks after the start of
clustered ephrin-A1-Fc infusion, the ephrin infusion enhanced
almost 4 times the number of double-labeled cells over infusion of
clustered IgG(Fc) (Fig. 5B). Unclustered ephrin-A1-Fc did not
increase the number of double-labeled cells beyond that induced
by IgG(Fc) (data not shown). In the granule layer of the olfactory
bulb, we also found that the number of double-labeled cells
significantly increased after treatment with clustered ephrin-A1-Fc
(Fig. 5C). However, the ratio of BrdU(+)CM-DiI(+) cells over
BrdU(+) cells, which is around 1/3, stayed almost same in
treatment with clustered IgG(FC) or ephrin-A1-Fc in both
striatum and olfactory bulb. The relative localization of CM-DiI
and BrdU in a cell level was clearly shown by staining with labeled
Wheat Germ Agglutinin that binds to cell surface carbohydrates
(Fig. 5D). The results indicate that many BrdU(+) cells were
labeled with CM-DiI at their surface.
Figure 2. Effect of clustered ephrin-A1-Fc injection in rats with
chemical lesions in the unilateral nigrostriatal dopaminergic
pathway. (A) Effect of intrastriatal injection of clustered ephrin-A1-Fc
on the regeneration of dopaminergic cells. Rats with unilateral
nigrostriatal lesions were injected with clustered IgG(Fc) (upper panels)
or ephrin-A1-Fc (lower panels) into the lesioned side of the striatum
near the subventricular zone. Rats were killed 6 weeks after injection.
Brains were sectioned coronally, and sections were stained immuno-
histochemically for tyrosine hydroxylase (TH). Yellow arrows indicate
the course of needles used for injection of clustered IgG(Fc) or ephrin-
A1-Fc. Scale bar: 100 mm. (B) Entire striatal coronal view of TH–positive
cells. Clustered IgG(Fc) or ephrin-A1-Fc was injected into the ventricle
ipsilateral to the lesioned side, and coronal sections of the entire
striatum were stained for TH. Upper panels, clustered IgG(Fc)-injected
rat; lower panels, clustered ephrin-A1-Fc-injected rat. Scale bar: 500 mm.
doi:10.1371/journal.pone.0032019.g002
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BrdU(+) cells had evidence of exposure to the lateral ventricle and
migrated from the ventricular area into the striatum. On the other
hand, there is no clear evidence on the origin of non-CM-DiI-
labeled BrdU(+) cells. Several reasons can be considered for this
non-labeling with CM-DiI; technical difficulty in detecting the
CM-DiI label, NSPCs not exposed to the ventricle, mitogenically
active cells residing in the striatum, etc. However, the finding that
clustered ephrin-A1-Fc increases the numbers of both
BrdU(+)CM-DiI(+) and BrdU(+) cells in the striatum as well as
in the olfactory bulb without changing their ratio suggests that the
double labeled cells are representing the BrdU(+) cells moving
from the SVZ.
Transformation of Subventricular Niche Cells
In rats that received 7-day continuous infusion of clustered
ephrin-A1-Fc (3 mg/day) into the lesioned side of the lateral
ventricle together with intraperitoneal 7-day BrdU injection
(80 mg/kg twice a day), the infused side showed many BrdU(+)
cells, densely distributed throughout the striatum and with high
localization in the SVZ (Fig S3). In the ephrin-A1-Fc infused side
of the brain the SVZ became thicker, and many BrdU(+) cells in
the SVZ and the adjacent area were also positive for GFAP
(Fig. 6A), suggesting that they are possibly adult neural stem cells
capable of further neuronal differentiation. However, it cannot be
excluded that GFAP (+) cells are astrocytes [2].
We counted the number of GFAP(+) cells in the striatum 500–
800 mm lateral from the ventricular surface in 8 microscopic areas
after treatment. Clustered ephrin-A1-Fc increased the number of
BrdU(+) cells as well as the percentage of GFAP(+)BrdU(+) cells
over control (IgG[Fc]) (Fig. 6B). In the same study, unclustered
ephrin-A1-Fc or FGF2 did not increase the BrdU(+) or GFAP(+)
cells. Microglial cells were also examined immunohistochemically
by staining for ionized calcium-binding adapter molecule 1 (Iba1).
These consistently represented 32% to 35% of BrdU(+) cells in
response to any treatment (data not shown), suggesting that they
presumably appeared in response to 6OHDA damage [39].
The same SVZ cells on the lesioned side were examined by
triple-staining for GFAP, CD24, and BrdU (Fig. 6C). When
clustered IgG(Fc) was infused, the lesioned side of the SVZ showed
a thin layer of GFAP(+) cells beneath a monolayer of CD24–
positive ependymal cells facing the lateral ventricle. However,
clustered ephrin-A1-Fc induced thickening of the layer of GFAP(+)
cells without affecting the monolayer of ependymal cells. We
defined the width of SVZ as the thickness of GFAP staining
beneath the CD24 positive ependymal cells on the striatal side,
and measured the width in coronal sections at the middle of
antero-posterior and dorso-ventral axes. Rats infused with
clustered IgG(Fc) and ephrin-A1-Fc exhibited the width of
13.363.1 and 3564.5 mm, respectively (mean 6 SD; n=6;
p,0.001).
We also characterized the BrdU(+) cells in and around the SVZ
using neural progenitor cell markers. As shown in Fig. 6D, E, and
F, many BrdU(+) cells stained positive for MASH1, a marker for
transit-amplifying progenitor cells [40,41], and for Doublecortin
(DCX), a marker for neuroblasts, or Nestin, a marker for neural
stem cells and transit-amplifying progenitor cells. They are present
not only in the SVZ but also in the adjacent striatum, supporting
the migration scheme of BrdU(+) cells from the SVZ to the
striatum.
Differentiation of BrdU(+) cells to Neurons after
Intraventricular Infusion of Clustered Ephrin-A1-Fc
To study whether BrdU(+) cells differentiate to neurons, we
counted the numbers of BrdU(+) cells and those of cells double-
labeled for NeuN (neuronal nuclei) and BrdU 4 weeks after a 1-
week infusion of clustered ephrin-A1-Fc in striatal sections of the
unilaterally lesioned rats (Fig. 7A; Fig S4). Clustered ephrin-A1-
Fc increased the number of BrdU(+) cells on the lesioned,
infused side of the striatum significantly more than 2-fold
compared to the lesioned, clustered IgG(Fc)-infused side
(p,0.01; 444.8683.5 vs. 186.8648.9; n=6). Clustered ephrin-
A1-Fc did not affect the number of BrdU(+)c e l l so nt h e
contralateral side of the striatum in the same rats. The
Figure 3. Behavioral effects of clustered ephrin-A1-Fc injection into the lateral ventricle. Effect of a single injection (3 mg) (A) or a 1-week
infusion with a micro-osmotic pump (B) of clustered ephrin-A1-Fc (2 mg/day) or control (clustered IgG[Fc]). Production of rats with unilateral
nigrostriatal lesions and evaluation of behavior after intraperitoneal injection of apomorphine were performed as described in the Materials and
Methods. (A) Behavior was analyzed just before and 6 weeks after injection of clustered IgG(Fc) or ephrin-A1-Fc. In each animal, the value of rotation
frequency at 6-week point was adjusted to that before injection. Mean of the adjusted values in control animals at 6-week point was set at 100%.
Error bars represent SD. *p,0.01 (n=7). (B) Behavioral analysis was performed in lesioned rats infused with clustered IgG(Fc) (n=5; white bars) or
clustered ephrin-A1-Fc (n=5; black bars) every 4 weeks up to 12 weeks from the start of infusion. In each group, the mean rotation value before
infusion was taken as 100%. Error bars represent SD. *p,0.01 compared to the control.
doi:10.1371/journal.pone.0032019.g003
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increased significantly on the lesioned, clustered ephrin-A1-Fc-
infused side compared to the lesioned, clustered IgG(Fc)–infused
side (10.30%61.75% vs. 3.39%60.76%; p,0.01; n=6).
Importantly, some of the BrdU(+) cells were also TH(+) (Fig. 7B).
These were distributed most densely in the striatum close to the
anteroventral region of the clustered ephrin-A1-Fc-infused lateral
ventricle. Three dimensional confocal imaging of 6 areas
Figure 4. Distribution of BrdU(+) cells in the striatum after intraventricular injection of clustered ephrin-A1-Fc. (A) Pulse-chase
experiments of BrdU labeling of proliferating cells. Unilaterally lesioned rats were injected with a single dose of clustered ephrin-A1-Fc (3 mg) into the
lateral ventricle of the lesioned side, followed by 3 intraperitoneal injections of BrdU at 6-hour intervals. Coronal sections of brains were examined 1,
7, and 14 days after injection of clustered ephrin-A1-Fc. BrdU staining is shown as fine green dots in the striatum. TH staining was used to detect the
lesioned side of the brain (not shown). Lesioned sides are shown on the left, and normal sides are shown on the right. The numbers of days after
clustered ephrin-A1-Fc injection (Day 0) are shown above the panels. Upper panels represent the anterior part of the striatum, and lower panels
represent the middle region of the striatum. Vertical white bars show the intra-striatal distribution front of BrdU(+) cells. (B) Enlarged
photomicrographs of the numbered regions in (A). (C) The same as (A) except that clustered IgG(Fc) (3 mg) instead of clustered ephrin-A1-Fc was
injected as control. Only the middle region of the striatum is shown. (D) Enlarged photomicrographs of the numbered regions of (C). Scale bar:
100 mm. These are the typical results of 3 separate experiments for each treatment.
doi:10.1371/journal.pone.0032019.g004
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4 mm
2/area and 10 mm thickness) of this region from 3
lesioned, clustered ephrin-A1-Fc-infused rats revealed 42 TH(+)
cells among 488 BrdU(+) cells (8.661.14%; n=3). No TH(+) cells
were identified in the lesioned side of the striatum infused with
clustered IgG(Fc), unclustered ephrin-A1-Fc, or FGF2. Almost all
TH(+) cells were positive for dopamine transporter (Fig. 7C).
Vascular Development after Intraventricular Infusion of
Clustered Ephrin-A1-Fc
Ephrin-A1 induces angiogenesis in tumors as well as in
embryonic and adult tissues [19]. To study whether the same
effect of ephrin-A1 can be detected in the brain, clustered ephrin-
A1-Fc (3 mg/day) was infused into the lesioned side of the lateral
ventricle in the unilaterally lesioned rats. Brain taken from the rats
6 weeks after the start of infusion were sectioned coronally and
stained for BrdU and Rat Endothelial Cell Antigen-1 (RECA-1).
Treatment with clustered ephrin-A1-Fc increased BrdU(+) cells
and enhanced the percentage of BrdU(+) RECA-1(+) cells
(Fig. 8A). In the striatum of clustered ephrin-A1-Fc-infused rats,
GFAP(+) astrocytic cells were juxtaposed to RECA-1(+) endothe-
lial cells (Fig. 8B; Fig S5), and the endothelial cell area measured as
the area of RECA-1 staining was almost twice that of clustered
IgG(Fc)-injected rats (Fig. 8C). In the experiment using intraven-
tricular injection of CM-DiI right before infusion of clustered
ephrin-A1-Fc, some endothelial cells were double-labeled with
CM-DiI and BrdU, suggesting that they were derived from the
cells once facing the lateral ventricle, and presumably migrated to
the striatum (Fig. 8D).
Discussion
The present results indicate that subventricular cells are induced
to increase their number, migrate to the striatum, and differentiate
in the striatum after injection of clustered ephrin-A1-Fc into the
lateral ventricle. A recent report indicates that normal neural stem
cells (NSCs, B1 cells) in the SVZ possess a monociliated process
that directly contacts the ventricular lumen [42]. A cluster of these
apical processes is surrounded by ependymal cells. The cilia of the
ependymal cells (E1 and E2) encircling the B1 stem cell processes
may serve to concentrate soluble factors in the cerebrospinal fluid
and induce contact of these factors with the apical processes of B1
cells. Similar signaling via primary cilia of stem cells is reported
with hedgehog signals in the SGZ [43]. Alternatively, ependymal
cells surrounding B1 cells might mediate signal to NSCs. However,
it is less likely that clustered ephrin-A1-Fc diffuses through the
ependymal layer into the brain tissue as it has a large mass, even if
ependymal cells do not have tight junctions [44]. In either case,
intraventricular infusion of clustered ephrin-A1-Fc appears to
transform the subventricular stem cell niche, enlarging the width
of the subventricular zone without affecting the ependymal layer.
Figure 5. Tracking BrdU(+) cells following intraventricular infusion of clustered ephrin-A1-Fc. Unilaterally lesioned rats were infused with
clustered IgG(Fc) or clustered ephrin-A1-Fc into the lateral ventricle of the lesioned side for 1 week with simultaneous intraperitoneal injection of
BrdU. (A) Number of BrdU(+) cells in the striatum counted with a stereologic counting system. n=4 for the clustered IgG(Fc)-infused and ephrin-A1-
Fc-infused groups. Error bars represent SD. *p,0.05 (Mann Whitney test, n=4) compared to clustered IgG(Fc). (B) Tracking the cells labeled with BrdU
and CM-DiI in the striatum. Brain slices were stained for BrdU and with Wheat Germ Agglutinin (WGA), and confocal 3D micrographs were taken at 1-
mm intervals. Then, ten serial confocal micrographs were compiled for one all-in-focus micrograph, and the number of cells labeled with BrdU or co-
labeled with both BrdU and CM-DiI was counted in defined areas as described in the Materials and Methods. **p,0.01 (n=8) compared to IgG(Fc).
(C) Tracking of the cells labeled with BrdU and CM-DiI in the olfactory bulb. Study protocols are the same as in (B). The labeled cells in the granule cell
layer of the olfactory bulb were counted. *p,0.05 (n=8) compared to IgG(Fc). (D) A typical confocal micrograph showing the relative localization of
BrdU (blue), WGA (green) and CM-DiI (red) in a cell level in the striatum. Scale bar, 20 mm; arrowheads, cells labeled with both BrdU and CM-DiI.
doi:10.1371/journal.pone.0032019.g005
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are localized to the SVZ; the recombinant ephrin-A1-Fc affected
only the ventricular side when injected into the striatum close to
the ventricle. These findings strongly support that the subven-
tricular NSPCs are the major cells affected by injection of
clustered ephrin-A1-Fc into the lateral ventricle.
Recent studies show complicated results on the function of
ephrins and Ephs in neurogenesis. Ephrins A2 and A5, and their
receptor EphA7, regulate neural stem cell survival and prolifer-
ation in the embryonic telencephalon [23]. Ephrin-A2 reverse
signaling mediates antiproliferative effects in the adult SVZ [22].
Endogenous ephrin-A2 and -A3 expressed in astrocytes appear to
form an inhibitory niche that negatively regulates neural
progenitor cell proliferation in adult mammalian brain areas
other than the SGZ of the hippocampus and the SVZ [45]. On the
other hand, EphA4 is shown to be important to maintain postnatal
and adult neural stem cells in vivo [21], and EphA2, A3 and A4
appears to be important for neuronal differentiation [20]. Some
ephrin-Bs and EphBs appear to be involved in suppression of
NSPC proliferation in the neurogenic niche [25,26,28], whereas
others are involved in proliferation or at least maintenance of
NSPCs [24,27,29]. Of course, different ephrins might have
Figure 6. Effect of intraventricular infusion of clustered ephrin-A1-Fc on the distribution of immunostained cells in the striatum.
Unilaterally lesioned rats were treated as for Fig. 5. BrdU is shown in green, and GFAP in red. (A) Magnification of the rectangular inset in Fig S3. White
arrowheads indicate the cells positive for both BrdU and GFAP outside of the SVZ. Scale bar: 50 mm. (B) BrdU(+) cells and BrdU(+)&GFAP(+) cells were
counted as described in the Materials and Methods. Total numbers of BrdU(+) cells in 8 animals are shown on the left, and percentages of GFAP(+)
cells among BrdU(+) cells are shown on the right. Error bars represent SD. *p,0.01 (n=8) compared to control (IgG[Fc]). (C) Triple staining of the
lesioned side of the subventricular region after infusion of clustered ephrin-A1-Fc or IgG(Fc). CD24, green; GFAP, red; BrdU, blue. Scale bar: 20 mm.
(D) Staining for MASH1 (green) and BrdU (red) in and around the SVZ 6 weeks after infusion of clustered ephrin-A1-Fc. White arrowheads indicate the
cells positive for both MASH1 and BrdU. (E) Staining for Doublecortin (DCX) (red) and BrdU (green) in and around the SVZ 6 weeks after infusion of
clustered ephrin-A1-Fc. White arrowheads indicate the cells positive for both DCX and BrdU. (F) Staining for Nestin (red) and BrdU (green) in and
around the SVZ 6 weeks after infusion of clustered ephrin-A1-Fc. In (D), (E) and (F), the lateral ventricle is toward the right side of the panel, and the
dotted line indicates the border between the lateral ventricle and the ependymal cell layer. Scale bar: 20 mm.
doi:10.1371/journal.pone.0032019.g006
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complicating effects could be explained by the experimental
system used for each study. We suspect that our strategy of ectopic
application of clustered ephrin-A1-Fc from inside the ventricle, in
which clustered ephrin stays out of the tissue and affects only from
the side of cerebral fluid, might differ from endogenous expression
or deletion via genetic engineering in that it elicits forward
signaling with barely affecting the reverse signaling. However, we
cannot completely exclude the possibility that some clustered
ephrin diffuses into the SVZ tissue, and stimulates the forward
signaling and blocks the reverse signaling.
Pulse-chase experiments and CM-DiI labeling from the
ventricular side demonstrated that BrdU(+) cells migrated
extensively from the SVZ to the striatum after injection of
clustered ephrin-A1-Fc into the lesioned side of the lateral
ventricle. Staining of the cells with several cell markers, Nestin
Figure 7. Differentiation of BrdU(+) cells to neuronal cells in the striatum. The brain of a unilaterally lesioned rat treated as in Fig. 6 was
sectioned coronally and immunostained for NeuN and BrdU. (A) Left panel, number of cells positive for BrdU alone (white bars) and for both BrdU
and NeuN (black bars) in the striatum. Cell numbers were counted in 6 animals using the dynamic cell count program of the Keyence fluorescence
microscopy system. *p,0.01 (n=6) compared to values for the side of clustered ephrin-A1-Fc infusion. Right panel, ratio of the number of
NeuN(+)&BrdU(+)cells to that of BrdU(+) cells. *p,0.01 (n=6) compared to values for the side of clustered ephrin-A1-Fc infusion. Error bars indicate
SD. (B) BrdU(+) cells differentiating to the TH(+) neuronal lineage as detected by confocal microscopy. BrdU(+) nuclei are shown in green, and
cytoplasmic TH in red. Merged regions are shown in yellow. 3D confocal photomicrographs are indicated by vertical (red) and horizontal (green) lines.
Blue lines indicate the depth of the confocally sectioned plane relative to the top surface located close to the enface micrograph. Scale bar: 20 mm.
(C) Co-localization of dopamine transporter (DAT) and TH in a regenerated neuron fiber. Sections were stained for DAT (green) and TH (red), and
analyzed by confocal microscopy. Scale bar: 10 mm.
doi:10.1371/journal.pone.0032019.g007
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migrating cells in and around the SVZ are neural stem cells,
transit-amplifying cells and neuroblasts. Migration occurred on the
lesioned side of the striatum only after ipsilateral intraventricular
injection. The normal side was barely affected unless ephrin was
injected into this side of the lateral ventricle. In addition to the
above-mentioned signaling mechanisms via stem cell cilia or
ependymal cells [42], increased sensitivity of cells residing on the
damaged side might play a role in this effect [8,9]. Migration of
BrdU(+) cells via the default rostral migratory stream, as shown in
our control studies, was also augmented heavily by clustered
ephrin-A1-Fc and moderately by FGF2, suggesting that the effect
of clustered ephrin-A1-Fc on striatal migration is not a nonspecific
phenomenon. The molecular mechanisms of cellular migration
involve cytoskeletal changes induced by a dynamic structural shift
of actin microfilaments and microtubules in response to external
Figure 8. Effect of clustered ephrin-A1-Fc on vascular formation in the rat striatum. (A) Distribution of BrdU(+) endothelial cells. Brain of
the unilaterally lesioned rats 6 weeks after infusion of clustered ephrin-A1-Fc were sectioned coronally and stained for BrdU and Rat Endothelial Cell
Antigen-1 (RECA-1). Numbers of the BrdU(+) cells and BrdU(+)&RECA-1(+) cells were counted as describe in the Materials and Methods. Total numbers
of BrdU(+) cells in 8 animals are shown on the top, and percentages of RECA-1(+) cells among BrdU(+) cells are shown on the bottom. Error bars
represent SD. *p,0.01 (n=8) compared to control (IgG[Fc]). (B) Magnified confocal micrographs of insets in Fig S5. Scale bar: 50 mm.
(C) Quantification of endothelial cell area. Coronal sections of striatum were stained for RECA-1 as in Fig S5, and the RECA-1 stained area was
quantified using an ImageJ computer program (NIH). The areas taken for measurements were as described in the Materials and Methods. The values
from 6 animals were analyzed statistically. *p,0.01 (n=6). Error bars represent SD. (D) Co-localization of BrdU, CM-DiI, and RECA-1 in endothelial cells
of the striatum. Sections taken from the rats treated as in Fig. 5B with intraventricular CM-DiI injection were stained for BrdU and RECA-1 and
subjected to 3D confocal microscopy. Micrographs are the all-in-focus compilation of 12 confocal micrographs at 0.5 mm intervals.
doi:10.1371/journal.pone.0032019.g008
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mediated by RhoA activation following complex formation of
FGFR, EphA4 and ephexin1, which depends on EphA4
activation, is at least partially involved in the mechanism of stem
cell migration into the striatum [13,36]. In this case, FGFR is
responsible for activation of the Rho family guanine nucleotide
exchange factor, ephexin1. We have shown that all four classes of
FGFRs and ephexin1 are also expressed in the SVZ, and EphA4,
a predominant Eph that binds to recombinant ephrin-A1-Fc in the
SVZ, is phosphorylated in the SVZ cells of rats intraventricularly
infused with clustered ephrin-A1-Fc. Examining this way of
signaling, we performed injection of SU5402, an FGFR inhibitor,
into the lateral ventricle to test if the function of clustered ephrin-
A1-Fc can be blocked. We have preliminary data to be completed
showing that the inhibitor suppresses not only migration of
BrdU(+) cells into the striatum but also recovery from the typical
rotational behavior induced by apomorphine injection in the rats
with a unilaterally lesioned nigrostriatal dopaminergic pathway.
Injection of clustered ephrin-A1-Fc into the lateral ventricle
induced histologic and behavioral improvements in the unilaterally
lesioned rats. A single injection (3 mg) into the lesioned side of the
lateral ventricle improved apomorphine-induced rotating behavior
significantly. Continuous infusion for 1 week with a dose of 2 mg/
day produced even greater improvements. The effect of ephrin
injection on these histologic and behavioral improvements was
evident 12 weeks after ephrin injection. This behavioral recovery is
most likely to be caused by differentiation of NSPCs to astrocytes
and dopaminergic neurons. Regeneration of damaged but surviving
residual dopaminergic fibers might be induced by infusion of
clustered ephrin-A1-Fc into the lateral ventricle, and had some
functions in the behavioral improvement. However, we waited for 6
weeks after 6OHDA injection, and confirmed almost complete
depletion of dopaminergic neural fibers in the striatum right before
ephrin-A1-Fc infusion. We found that a major proportion of
BrdU(+) cells migrating through the striatum differentiated to
astrocytes when stimulated by clustered ephrin-A1-Fc from inside
the lateral ventricle, and that differentiation of BrdU(+) cells to
dopaminergic neurons also occurred in the striatum. Differentiation
of subventricular NSPCs to dopaminergic neurons by ephrin-A
ligands has been reported in an in vitro study, and appears to be
mediated by MAP kinase activation [20]. Astrocytes generally
interact with neurons directly [49] and play an important role in
supporting neurons. In the RMS, chains of migrating adult
neuroblasts are ensheathed by astrocytes [50]. They express
cytokines and cytokine receptors; other factors that act as
neuroprotective agents of damaged neurons [51,52]; constituents
of the niche microenvironment [53]; differentiation/maturation
factors [54]; and synaptogenic factors [54]. Thus, newly differen-
tiated astrocytes in response to clustered ephrin-A1-Fc injection are
suspected to play a critical role in differentiation of neural stem cells
to dopaminergic neurons and their maintenance in the striatum.
Another finding is that clustered ephrin-A1-Fc increased
angiogenesis in the striatum on the injected side. Ephrins and
their Eph receptors are known to regulate angiogenesis [19].
Originally, B-class receptors and ligands were considered impor-
tant players in endothelial cell migration and differentiation,
leading, in concert with other growth factors, to capillary
formation. Recent studies demonstrate the additional involvement
of ephrin-A1 and EphA2 in postnatal and tumor angiogenesis
[55]. Intraventricularly injected clustered ephrin-A1-Fc likely
increased capillary formation via binding to receptors on
ependymal cells or B1 neural stem cells that directly contact the
ventricular fluid, as subventricular capillary vessels locate far from
the ventricular surface [7,42]. In either case, signaling for
endothelial cell proliferation appears to be indirect. However,
the finding of endothelial cells double-labeled with BrdU and CM-
DiI suggests a possibility that neural stem cells differentiate to
endothelial cells. This kind of transdifferentiation has been
reported in neural stem cells in vivo [56]. Subventricular capillary
vessels, once formed, are permeable to small molecules; this
facilitates access of stem cells and transit-amplifying cells to
molecules in the bloodstream such as growth factors, hormones,
and nutrients [7]. Ephrin-A1 further increases this vascular
permeability upon stimulation of its receptor EphAs as demon-
strated in the lung [57]. Thus, clustered ephrin-A1-Fc appears to
stimulate angiogenesis by inducing stem cell proliferation in the
SVZ. In turn, the enhanced angiogenesis would help increase the
stem cell proliferation as well.
In conclusion, injection of clustered ephrin-A1-Fc into the
lateral ventricle induced transformation of the subventricular
niche, resulting in increase of BrdU(+) NSPCs in and around the
SVZ, their migration to the striatum, their differentiation to
astrocytes and neuronal cells, including dopaminergic cells, and
angiogenesis. Owing to this dopaminergic regeneration supported
by increasing numbers of astrocytes and capillary vessels in the
striatum, behavioral abnormalities caused by lesion to the
nigrostriatal pathway decreased dramatically. These findings
may lead to the development of new therapeutic approaches for
neurodegenerative diseases such as Parkinson’s disease and related
disorders in humans.
Supporting Information
Figure S1 Effect of clustered ephrin-A1-Fc injection in
rats with chemical lesions in the unilateral nigrostriatal
dopaminergic pathway. (A and B) Effect of intraventricular
injection of clustered ephrin-A1-Fc on the regeneration of TH–
positive cells. Six weeks after clustered ephrin-A1-Fc or IgG(Fc)
was injected into the ventricle ipsilateral to the lesioned side,
coronal sections of the striatum near the lateral ventricle were
stained for TH (red in A and green in B). (A) Lesioned (left panel)
and normal (right panel) sides of the subventricular and striatal
area after injection of clustered ephrin-A1-Fc. (B) Lesioned side
after injection of clustered IgG(Fc) (left panel) or clustered ephrin-
A1-Fc (right panel). Scale bar: 100 mm.
(DOC)
Figure S2 Effect of intraventricular infusion of ephrin-
A1-Fc on the distribution of BrdU(+) cells in the striatum
and olfactory bulb. Unilaterally lesioned rats were infused with
clustered IgG(Fc) (3 mg/day), unclustered ephrin-A1-Fc (3 mg/
day), clustered ephrin-A1-Fc (3 mg/day), or FGF2 (50 ng/day)
into the lateral ventricle of the lesioned side with simultaneous
intraperitoneal injection of BrdU twice a day. Brains were
removed 6 weeks after the start of infusion, sliced into 40-mm
thick coronal sections, and stained for BrdU. Numbers of BrdU(+)
cells were counted in 8 areas of coronal sections of striatum or
sagittal sections of the granule cell layer of the olfactory bulb as
described in Materials and Methods. We used 8 animals. Error
bars represent SD. *p,0.01 (n=8) compared to clustered IgG(Fc).
(DOC)
Figure S3 Effect of intraventricular infusion of clus-
tered ephrin-A1-Fc on the distribution of BrdU(+) and
GFAP(+) astrocytic cells. Unilaterally lesioned rats were
treated as for Fig. 5. Confocal micrographs are shown with BrdU
in green and GFAP in red. The rectangular inset is magnified in
Fig. 6A with split colors. Scale bar: 100 mm.
(DOC)
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cells. The brain of a unilaterally lesioned rat treated as in Figs. 5
and 6 was sectioned coronally and immunostained for NeuN and
BrdU. Immunostained cells in the striatum were detected by
confocal microscopy. Cells positive for both NeuN and BrdU are
indicated by arrowheads. Scale bar: 20 mm.
(DOC)
Figure S5 Effect of clustered ephrin-A1-Fc on vascular
formation in the rat striatum. Clustered ephrin-A1-Fc was
injected into the lesioned side of the lateral ventricle in the
unilaterally lesioned rats. Brains taken 6 weeks after injection were
sectioned coronally and stained for GFAP (green) and RECA-1
(red) and with DAPI (nuclei; blue). The rectangular insets are
shown in Fig. 8B. Scale bar: 100 mm.
(DOC)
Table S1 Oligonucleotide primers used in this Study.
Prefix r indicates rat; suffixes -F and -R indicate forward and
reverse, respectively. Gapdh, glyceraldehyde 3 phosphate dehydro-
genase; Frs2a, fibroblast growth factor receptor substrate 2a; Fgfr,
fibroblast growth factor receptor.
(DOC)
Table S2 Antibodies used in this Study. FRS2a, fibroblast
growth factor receptor substrate 2a; FGFR, fibroblast growth
factor receptor.
(DOC)
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